Filgotinib
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Filgotinib and local guidelines before prescribing.
JAK inhibitor
Mechanism
JAK1 inhibitor.
Uses
Rheumatoid arthritis, ulcerative colitis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Infections, VTE, raised lipids, reduced sperm count.
Interactions
Few.
Contraindications and cautions
Active infection
Monitoring
FBC, lipids
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Avoid in severe renal impairment
Overdose and reversal
Supportive
Special advice
MHRA JAK caution groups apply.
More from the textbook: uses, cautions and other points
- Tofacitinib , upadacitinib , filgotinib | JAK inhibitors (oral) | Fast acting; MHRA - increased risk of VTE , major cardiovascular events, cancer and serious infection: avoid in people over 65, smokers and those with cardiovascular or cancer risk unless no alternative; shingles (vaccinate); raised lipids; teratogenic
Gastroenterology: Anatomy Physiology Pharmacology - Tofacitinib / filgotinib / upadacitinib | Oral JAK inhibitors; MHRA caution over 65, smokers, CV or cancer risk; VTE; shingles; avoid in pregnancy.
Gastroenterology: Inflammatory Bowel Disease - JAK (small molecules) | Tofacitinib, baricitinib, upadacitinib, filgotinib | RA, psoriatic arthritis, axial SpA — caution over 65s and smokers (MHRA)
Rheumatology Anatomy Physiology Pharmacology - Tofacitinib and filgotinib (UC), upadacitinib (UC and Crohn's).
Gastroenterology: Inflammatory Bowel Disease - Oral targeted synthetic DMARDs - tofacitinib, baricitinib, upadacitinib, filgotinib - block Janus kinase signalling (many cytokines at once).
Rheumatology: assessment, investigations and drugs
Where it is discussed in the book
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Inflammatory Bowel Disease (2 mentions)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (1 mention)